MENU
+Compare
VNRX
Stock ticker: ASE
AS OF
Apr 24, 04:59 PM (EDT)
Price
$0.49
Change
+$0.01 (+2.08%)
Capitalization
62.13M

VNRX VolitionRX Limited Forecast, Technical & Fundamental Analysis

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19... Show more

VNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for VNRX with price predictions
Apr 23, 2025

VNRX in upward trend: price expected to rise as it breaks its lower Bollinger Band on April 07, 2025

VNRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 42 cases where VNRX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Momentum Indicator moved above the 0 level on April 23, 2025. You may want to consider a long position or call options on VNRX as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VNRX advanced for three days, in of 225 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for VNRX turned negative on April 07, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VNRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for VNRX entered a downward trend on April 14, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.331) is normal, around the industry mean (23.728). P/E Ratio (0.000) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (70.922) is also within normal values, averaging (41.794).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. VNRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VNRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
VNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

VNRX is expected to report earnings to fall 41.67% to -3 cents per share on May 07

VolitionRX Limited VNRX Stock Earnings Reports
Q1'25
Est.
$-0.04
Q4'24
Est.
$-0.05
Q3'24
Est.
$-0.07
Q2'24
Beat
by $0.01
Q1'24
Est.
$-0.10
The last earnings report on March 31 showed earnings per share of -5 cents, missing the estimate of -5 cents. With 80.10K shares outstanding, the current market capitalization sits at 62.13M.
A.I. Advisor
published General Information

General Information

a development stage life sciences company

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Or Nursing Services
Address
1489 West Warm Springs Road
Phone
+1 646 650-1351
Employees
110
Web
https://www.volition.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ISRG487.939.19
+1.92%
Intuitive Surgical
NRT4.370.08
+1.86%
North European Oil Royalty Trust
USPH68.750.88
+1.30%
US Physical Therapy
CBSH60.380.29
+0.48%
Commerce Bancshares Inc
OIS3.46-0.05
-1.42%
OIL States International

VNRX and Stocks

Correlation & Price change

A.I.dvisor tells us that VNRX and STRRP have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VNRX and STRRP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNRX
1D Price
Change %
VNRX100%
N/A
STRRP - VNRX
27%
Poorly correlated
+0.33%
SRDX - VNRX
25%
Poorly correlated
+0.24%
VAPO - VNRX
25%
Poorly correlated
N/A
RMD - VNRX
23%
Poorly correlated
+0.17%
APYX - VNRX
23%
Poorly correlated
-4.52%
More